Structural basis of substrate methylation and inhibition of SMYD2

Structure

Volumn 19, Issue 9, 2011, Pages 1262-1273

  Ferguson, Andrew D ^a   Larsen, Nicholas A ^a   Howard, Tina ^a   Pollard, Hannah ^a   Green, Isabelle ^a   Grande, Christie ^a   Cheung, Tony ^a   Garcia Arenas, Renee ^a   Cowen, Scott ^a   Wu, Jiaquan ^a   Godin, Robert ^a   Chen, Huawei ^a   Keen, Nicholas ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZ 505; PROTEIN P53; PROTEIN SMYD2; TUMOR PROTEIN; UNCLASSIFIED DRUG;

BINDING SITE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DRUG PROTEIN BINDING; METHYLATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW;

EID: 80052473151     PISSN: 09692126     EISSN: 18784186     Source Type: Journal    
DOI: 10.1016/j.str.2011.06.011     Document Type: Article

References (44)

1. M. Abu-Farha, J.-P. Lambert, A.S. Al-Madhoun, F. Elisma, I.S. Skerjanc, and D. Figeys The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase Mol. Cell. Proteomics 7 2008 560 572 (Pubitemid 351472465)
2. M. Albert, and K. Helin Histone methyltransferases in cancer Semin. Cell Dev. Biol. 21 2010 209 220
3. N.A. Baker, D. Sept, S. Joseph, M.J. Holst, and J.A. McCammon Electrostatics of nanosystems: application to microtubules and the ribosome Proc. Natl. Acad. Sci. USA 98 2001 10037 10041 (Pubitemid 32802969)
4. B.E. Bernstein, T.S. Mikkelsen, X. Xie, M. Kamal, D.J. Huebert, J. Cuff, B. Fry, A. Meissner, M. Wernig, and K. Plath A bivalent chromatin structure marks key developmental genes in embryonic stem cells Cell 125 2006 315 326
5. R. Bonasio, S. Tu, and D. Reinberg Molecular signals of epigenetic states Science 330 2010 612 616
6. G. Bricogne, E. Blanc, M. Brandl, C. Flensburg, P. Keller, W. Paciorek, P. Roversi, O.S. Smart, C. Vonrhein, and T.O. Womack BUSTER version 2.8.0 2009 Global Phasing Ltd. Cambridge, United Kingdom
7. M.A. Brown, R.J. Sims 3rd, P.D. Gottlieb, and P.W. Tucker Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex Mol. Cancer 5 2006 26 37
8. V. Campagna-Slater, M.W. Mok, K.T. Nguyen, M. Feher, R. Najmanovich, and M. Schapira Structural chemistry of the histone methyltransferases cofactor binding site J. Chem. Inf. Model. 51 2011 612 623
9. CCP4 (Collaborative Computational Project, Number 4) The CCP4 suite: programs for protein crystallography Acta Crystallogr. D Biol. Crystallogr. 50 1994 760 763
10. Y. Chang, X. Zhang, J.R. Horton, A.K. Upadhyay, A. Spannhoff, J. Liu, J.P. Snyder, M.T. Bedford, and X. Cheng Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294 Nat. Struct. Mol. Biol. 16 2009 312 317
11. Y. Chang, T. Ganesh, J.R. Horton, A. Spannhoff, J. Liu, A. Sun, X. Zhang, M.T. Bedford, Y. Shinkai, J.P. Snyder, and X. Cheng Adding a lysine mimic in the design of potent inhibitors of histone lysine methyltransferases J. Mol. Biol. 400 2010 1 7
12. X. Cheng, R.E. Collins, and X. Zhang Structural and sequence motifs of protein (histone) methylation enzymes Annu. Rev. Biophys. Biomol. Struct. 34 2005 267 294 (Pubitemid 40847726)
13. H.G. Chin, D. Patnaik, P.O. Estve, S.E. Jacobsen, and S. Pradhan Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis Biochemistry 45 2006 3272 3284 (Pubitemid 43376346)
14. S. Chuikov, J.K. Kurash, J.R. Wilson, B. Xiao, N. Justin, G.S. Ivanov, K. McKinney, P. Tempst, C. Prives, and S.J. Gamblin Regulation of p53 activity through lysine methylation Nature 432 2004 353 360 (Pubitemid 39551664)
15. R.A. Copeland, M.E. Solomon, and V.M. Richon Protein methyltransferases as a target class for drug discovery Nat. Rev. Drug Discov. 8 2009 724 732
16. J.F. Couture, E. Collazo, G. Hauk, and R.C. Trievel Structural basis for the methylation site specificity of SET7/9 Nat. Struct. Mol. Biol. 13 2006 140 146 (Pubitemid 43214717)
17. P. Emsley, B. Lohkamp, W.G. Scott, and K. Cowtan Features and development of Coot Acta Crystallogr. D Biol. Crystallogr. 66 2010 486 501
18. R.M. Eglen, T. Reisine, P. Roby, N. Rouleau, C. Illy, R. Bossé, and M. Bielefeld The use of AlphaScreen technology in HTS: current status Curr. Chem. Genomics 1 2008 2 10
19. B.Y. Feng, A. Shelat, T.N. Doman, R.K. Guy, and B.K. Shoichet High-throughput assays for promiscuous inhibitors Nat. Chem. Biol. 1 2005 146 148
20. P.D. Gottlieb, S.A. Pierce, R.J. Sims, H. Yamagishi, E.K. Weihe, J.V. Harriss, S.D. Maika, W.A. Kuziel, H.L. King, and E.N. Olson Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis Nat. Genet. 31 2002 25 32
21. R. Hamamoto, Y. Furukawa, M. Morita, Y. Iimura, F.P. Silva, M. Li, R. Yagyu, and Y. Nakamura SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells Nat. Cell Biol. 6 2004 731 740 (Pubitemid 39144478)
22. R. Hamamoto, F.P. Silva, M. Tsuge, T. Nishidate, T. Katagiri, Y. Nakamura, and Y. Furukawa Enhanced SMYD3 expression is essential for the growth of breast cancer cells Cancer Sci. 97 2006 113 118 (Pubitemid 43379478)
23. J. Huang, L. Perez-Burgos, B.J. Placek, R. Sengupta, M. Richter, J.A. Dorsey, S. Kubicek, S. Opravil, T. Jenuwein, and S.L. Berger Repression of p53 activity by Smyd2-mediated methylation Nature 444 2006 629 632 (Pubitemid 44864441)
24. W. Kabsch XDS Acta Crystallogr. D Biol. Crystallogr. 66 2010 125 132
25. B.D.W. Karanikolas, M.L. Figueiredo, and L. Wu Polycomb group protein enhancer of zeste 2 is an oncogene that promotes the neoplastic transformation of a benign prostatic epithelial cell line Mol. Cancer Res. 7 2009 1456 1465
26. S. Komatsu, I. Imoto, H. Tsuda, K.I. Kozaki, T. Muramatsu, Y. Shimada, S. Aiko, Y. Yoshizumi, D. Ichikawa, E. Otsuji, and J. Inazawa Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma Carcinogenesis 30 2009 1139 1146
27. E. Krissinel On the relationship between sequence and structure similarities in proteomics Bioinformatics 23 2007 717 723 (Pubitemid 46554723)
28. S. Kubicek, R.J. O'Sullivan, E.M. August, E.R. Hickey, Q. Zhang, M.L. Teodoro, S. Rea, K. Mechtler, J.A. Kowalski, and C.A. Homon Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase Mol. Cell 25 2007 473 481 (Pubitemid 46206139)
29. J.E. Ladbury Calorimetry as a tool for understanding biomolecular interactions and an aid to drug design Biochem. Soc. Trans. 38 2010 888 893
30. F. Liu, X. Chen, A. Allali-Hassani, A.M. Quinn, G.A. Wasney, A. Dong, D. Barsyte, I. Kozieradzki, G. Senisterra, and I. Chau Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a J. Med. Chem. 52 2009 7950 7953
31. Y. Okada, Q. Feng, Y. Lin, Q. Jiang, Y. Li, V.M. Coffield, L. Su, G. Xu, and Y. Zhang hDOT1L links histone methylation to leukemogenesis Cell 121 2005 167 178 (Pubitemid 40546386)
32. G. Pan, S. Tian, J. Nie, C. Yang, V. Ruotti, H. Wei, G.A. Jonsdottir, R. Stewart, and J.A. Thomson Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells Cell Stem Cell 1 2007 299 312 (Pubitemid 47355329)
33. D. Patnaik, H.G. Chin, P.O. Estve, J. Benner, S.E. Jacobsen, and S. Pradhan Substrate specificity and kinetic mechanism of mammalian G9a histone H3 methyltransferase J. Biol. Chem. 279 2004 53248 53258 (Pubitemid 40051828)
34. P.H. Rooney, G.I. Murray, D.A. Stevenson, N.E. Haites, J. Cassidy, and H.L. McLeod Comparative genomic hybridization and chromosomal instability in solid tumours Br. J. Cancer 80 1999 862 873 (Pubitemid 29209852)
35. L.A. Saddic, L.E. West, A. Aslanian, J.R. Yates 3rd, S.M. Rubin, O. Gozani, and J. Sage Methylation of the retinoblastoma tumor suppressor by SMYD2 J. Biol. Chem. 285 2010 37733 37740
36. F.P. Silva, R. Hamamoto, M. Kunizaki, M. Tsuge, Y. Nakamura, and Y. Furukawa Enhanced methyltransferase activity of SMYD3 by the cleavage of its N-terminal region in human cancer cells Oncogene 27 2008 2686 2692 (Pubitemid 351581465)
37. N. Sirinupong, J. Brunzelle, J. Ye, A. Pirzada, L. Nico, and Z. Yang Crystal structure of cardiac-specific histone methyltransferase SmyD1 reveals unusual active site architecture J. Biol. Chem. 285 2010 40635 40644
38. N. Sirinupong, J. Brunzelle, E. Doko, and Z. Yang Structural insights into the autoinhibition and posttranslational activation of histone methyltransferase SmyD3 J. Mol. Biol. 406 2011 149 159
39. H.C. Tsai, and S.B. Baylin Cancer epigenetics: linking basic biology to clinical medicine Cell Res. 21 2011 502 517
40. C. Vonrhein, E. Blanc, P. Roversi, and G. Bricogne Automated structure solution with autoSHARP Methods Mol. Biol. 364 2007 215 230 (Pubitemid 350183137)
41. C. Vonrhein, C. Flensburg, P. Keller, A. Sharff, O. Smart, W. Paciorek, T. Womack, and G. Bricogne Data processing and analysis with the autoPROC toolbox Acta Crystallogr. D Biol. Crystallogr. 67 2011 293 302
42. H. Wu, J. Min, V.V. Lunin, T. Antoshenko, L. Dombrovski, H. Zeng, A. Allali-Hassani, V. Campagna-Slater, M. Vedadi, and C.H. Arrowsmith Structural biology of human H3K9 methyltransferases PLoS ONE 5 2010 e8570
43. J. Wu, T. Cheung, C. Grande, A.D. Ferguson, X. Zhu, K. Therault, E. Code, C. Birr, N. Keen, and H. Chen Biochemical characterization of human SET and MYND domain-containing protein 2 methyltransferase Biochemistry 2011 June 29. [Epub ahead of print]
44. X. Zhang, and T.C. Bruice Enzymatic mechanism and product specificity of SET-domain protein lysine methyltransferases Proc. Natl. Acad. Sci. USA 105 2008 5728 5732 (Pubitemid 351758440)